Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    " October 31, 2012":" November 30, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 31, 2012":" November 30, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed An Evaluation of a Rapid Test for HIV
Condition: HIV Seropositivity
Intervention: Device: Rapid testing for HIV
2 Active, not recruiting A Prospective, Observational Study to Examine the Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'
Conditions: HIV Positive;   Ageing
Intervention:
3 Terminated Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease
Condition: HIV Disease
Intervention: Biological: α1 Proteinase Inhibitor
4 Active, not recruiting Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Drug: EVG/COBI/FTC/TDF
5 Completed Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women
Condition: HIV
Intervention: Drug: maraviroc
6 Completed Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine
Condition: HIV
Interventions: Drug: Etravirine;   Drug: Darunavir/ritonavir;   Drug: artemether/lumefantrine
7 Active, not recruiting Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
Condition: Human Immunodeficiency Virus
Interventions: Drug: Busulfan;   Biological: Cal-1 modified HSPC;   Biological: Cal-1 modified CD4+ T lymphocytes
8 Active, not recruiting Black Men Evolving Behavioral HIV Prevention Intervention for Black MSM
Condition: HIV CDC Category A1
Intervention: Behavioral: B-ME Intervention
9 Unknown  Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
Conditions: Malaria in Pregnancy;   HIV Infection
Interventions: Drug: cotrimoxazole daily prophylaxis;   Drug: sulphadoxine-pyrimethamine
10 Recruiting Neurocognitive Effects of Opiate Agonist Treatment
Conditions: Opioid-Related Disorders;   HIV;   HIV Infections
Interventions: Drug: Buprenorphine;   Drug: Methadone
11 Unknown  A Pilot Trial of an Individualized Web-Based Condom Use Intervention
Condition: HIV
Intervention: Behavioral: Condom-HIM
12 Withdrawn A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients
Condition: Human Immunodeficiency Virus-Type 1
Intervention: Drug: No intervention
13 Unknown  A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.
Condition: HIV
Intervention: Drug: Darunavir, Ritonavir and Rilpivirine
14 Completed DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate
Condition: HIV
Interventions: Drug: dapivirine;   Drug: miconazole
15 Withdrawn A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid
16 Completed Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV Prevention
Interventions: Drug: Once Daily Application of TFV RG 1% Gel;   Drug: Once Daily Application of TFV RG 1% gel - Rectal;   Drug: Once Daily Application of TFV RG 1% Gel - Vaginal
17 Terminated A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: amdoxovir 300 mg bid;   Drug: amdoxovir 500 mg bid;   Drug: tenofovir DF 300 mg qd
18 Completed
Has Results
Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users
Conditions: HIV;   Opioid Dependence
Interventions: Behavioral: Community-friendly Health Recovery Program;   Behavioral: Time-and-Attention-Matched Control Condition
19 Completed Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
Conditions: HIV Infection;   Alcohol Use;   Bone Disease;   Substance-Related Disorders
Intervention:
20 Recruiting Doxycycline for COPD in HIV-Infected Patients
Conditions: HIV;   Chronic Obstructive Pulmonary Disease (COPD);   Emphysema
Interventions: Drug: Doxycycline;   Drug: Placebo (sugar pill)

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.